Cardinal Health’s first quarter results were received positively by the market, with management attributing performance to strong execution in its Pharmaceutical and Specialty Solutions business and ...

BrightSpring boosts 2025 guidance as Pharmacy and Provider segments post strong gains and margin initiatives take hold.

Cardinal Health, Inc. (NYSE:CAH), a key player in the healthcare services sector, operates within a framework influenced by ...

Cardinal Health (NYSE:CAH) is one of the best 52-week high stocks to buy, according to analysts. On June 10, analysts at TD ...

The global Traditional Wound Care Market , valued at US$7.15 billion in 2024, is forecasted to grow at a robust CAGR of 4.2%, ...

After digesting Cardinal Health's 2025 investor day, we inched up our 2026 revenue and EPS assumptions and lifted our stage II growth rates by 50 basis points to reflect a stronger distribution market ...

Raising long-term target for Pharmaceutical and Specialty Solutions profit to 5% ... DUBLIN, Ohio, June 12, 2025 /PRNewswire/ -- Cardinal Health ... including its pharmacy dispensing and ...

Capital deployment updates Cardinal Health continues to deploy capital according to its disciplined capital allocation framework. The company anticipates robust cash flow generation and plans to ...

Key announcements: Raising FY25 non-GAAP diluted EPS guidance to $8.15 to $8.201Establishing preliminary FY26 non-GAAP diluted EPS guidance of $9.10 to $9.30 (13% growth at the mid-points ...